The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the Solactive Emerging Markets Healthcare Index (the index). The fund will invest at least 80% of its total assets in components of the index, depositary receipts, representing such components, and securities underlying depositary receipts in the index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.